Artificial retinas give the blind only the barest sense of what’s visible, but researchers are working hard to improve that.
Susan YoungFollow @twitterapi
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
A biopharmaceutical company will know this year whether an antibody produced using a unique technique can prevent chronic migraines.
Genomics signatures in uterine cancers could offer clues to prognosis.
The impending Supreme Court ruling on gene patents is creating uncertainty in the molecular diagnostics sector.
A startup called Catabasis is developing drugs that hit diseases at multiple targets.
An easy-to-use EEG cap could expand the number of ways to interact with your mobile devices.
Mice tap into their own neural reward circuits with the help of a new optogenetics device.
Obama calls for $100 million to develop new technologies to understand the brain.
A microfluidic device that captures circulating tumor cells could give doctors a noninvasive way to diagnose and track cancers.